Menopausal Symptoms and Cardiovascular Disease Mortality in the Women’s Ischemia Syndrome Evaluation (WISE)

Ítems similars

• Timing of Hormone Therapy, Type of Menopause, and Coronary Disease in Women: Data from the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation (WISE)
  per: Shufelt, Chrisandra, et al.
  Publicat: (2011)
• SAT-LB99 Inflammation May Mediate Coronary Artery Disease in Women With Hypothalamic Hypoestrogenemia: Findings From the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation (WISE)
  per: Torbati, Tina, et al.
  Publicat: (2020)
• Carotid Artery Distensibility and Hormone Therapy and Menopause: The Los Angeles Atherosclerosis Study (LAAS)
  per: Shufelt, Chrisandra, et al.
  Publicat: (2016)
• Total Estrogen Time and Obstructive Coronary Disease in Women: Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE)
  per: Merz, C. Noel Bairey, et al.
  Publicat: (2009)
• DHEA-S Levels and Cardiovascular Disease Mortality in Postmenopausal Women: Results from the National Institutes of Health—National Heart, Lung, and Blood Institute (NHLBI)-Sponsored Women’s Ischemia Syndrome Evaluation (WISE)
  per: Shufelt, Chrisandra, et al.
  Publicat: (2010)